Your browser doesn't support javascript.
loading
R-CHOP-14 versus R-CHOP-14/CHASER for upfront autologous transplantation in diffuse large B-cell lymphoma: JCOG0908 study.
Kagami, Yoshitoyo; Yamamoto, Kazuhito; Shibata, Taro; Tobinai, Kensei; Imaizumi, Yoshitaka; Uchida, Toshiki; Shimada, Kazuyuki; Minauchi, Koichiro; Fukuhara, Noriko; Kobayashi, Hirofumi; Yamauchi, Nobuhiko; Tsujimura, Hideki; Hangaishi, Akira; Tominaga, Ryo; Suehiro, Youko; Yoshida, Shinichiro; Inoue, Yoshiko; Suzuki, Sachiko; Tokuhira, Michihide; Kusumoto, Shigeru; Kuroda, Junya; Yakushijin, Yoshihiro; Takamatsu, Yasushi; Kubota, Yasushi; Nosaka, Kisato; Morishima, Satoko; Nakamura, Shigeo; Ogura, Michinori; Maruyama, Dai; Hotta, Tomomitsu; Morishima, Yasuo; Tsukasaki, Kunihiro; Nagai, Hirokazu.
Afiliação
  • Kagami Y; Department of Hematology, Toyota Kosei Hospital, Toyota, Japan.
  • Yamamoto K; Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
  • Shibata T; Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
  • Tobinai K; JCOG Data Center/Operations Office, National Cancer Center, Tokyo, Japan.
  • Imaizumi Y; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Uchida T; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
  • Shimada K; Department of Hematology and Oncology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.
  • Minauchi K; Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Fukuhara N; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
  • Kobayashi H; Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan.
  • Yamauchi N; Department of Hematology, Saitama Cancer Center, Ina-cho, Japan.
  • Tsujimura H; Department of Hematology, National Cancer Center East, Kashiwa, Japan.
  • Hangaishi A; Division of Hematology-Oncology, Chiba Cancer Center, Chiba, Japan.
  • Tominaga R; Division of Hematology, NTT Medical Center Tokyo, Tokyo, Japan.
  • Suehiro Y; Division of Hematology, Hyogo Cancer Center, Akashi, Japan.
  • Yoshida S; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Inoue Y; Department of Hematology, National Hospital Organization Nagasaki Medical Center, Ohmura, Japan.
  • Suzuki S; Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
  • Tokuhira M; Hematology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan.
  • Kusumoto S; Departments of Hematology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
  • Kuroda J; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Yakushijin Y; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Takamatsu Y; First Department of Internal Medicine, Ehime University Hospital, Toon, Japan.
  • Kubota Y; Division of Medical Oncology, Hematology and Infectious Diseases, Department of Internal Medicine, Fukuoka University Hospital, Fukuoka, Japan.
  • Nosaka K; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
  • Morishima S; Department of Hematology, Kumamoto University Hospital, Kumamoto, Japan.
  • Nakamura S; Second Department of Internal Medicine, University of the Ryukyus Hospital, Nishihara, Japan.
  • Ogura M; Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan.
  • Maruyama D; Department of Hematology and Oncology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.
  • Hotta T; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Morishima Y; National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Tsukasaki K; Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
  • Nagai H; Department of Hematology, International Medical Center, Saitama Medical University, Hidaka, Japan.
Cancer Sci ; 111(10): 3770-3779, 2020 Oct.
Article em En | MEDLINE | ID: mdl-32767806
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B / Transplante de Células-Tronco Hematopoéticas / Quimioterapia de Indução Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Sci Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B / Transplante de Células-Tronco Hematopoéticas / Quimioterapia de Indução Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Sci Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão